March Tech Talk
Hosted by the Antibody and BioResource Core Facility
This seminar will provide a state-of-the-art overview of lipid nanoparticle (LNP) technologies beyond vaccines, highlighting their expanding role in gene therapy, immunomodulation, and regenerative medicine. Attendees will gain practical insight into advanced strategies for cell-type–specific delivery, including chemical conjugation approaches and bispecific antibody–mediated targeting. Participants will leave with a clear understanding of how next-generation functionalized LNPs can be engineered to improve precision, efficacy, and translational impact.